MENU
NBY
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
NovaBay Pharmaceuticals (NBY) Ownership - Who owns NovaBay Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
2000 Powell Street
Phone
+1 510 899-8800
Employees
26
Web
https://www.novabay.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.55M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
2.42M
Revenue
N/A
Risk (Beta)
0.52
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
9.57 USD as % of share price
Fundamentals
NBY
Capitalization
3.55M
P/E Ratio
N/A
Risk (Beta)
0.52
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
2.42M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
9.57%
Revenue
N/A
ROE
N/A
Book Value
-1.33M
P/B Ratio
3.33
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
320K
Current Ratio
0.92
Current Revenue Per Employee
101192.30
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
68.19
Revenue To Assets
N/A
Shares Held By Institutions
43.6K
Shares Outstanding - Current
4.89M
Total Liabilities
5.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-89.818
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
2000 Powell Street
Phone
+1 510 899-8800
Employees
26
Web
https://www.novabay.com